Marizyme, Inc. (MRZM)
OTCMKTS: MRZM · Delayed Price · USD
0.0500
-0.0430 (-46.24%)
Jul 22, 2024, 4:00 PM EDT - Market closed
Marizyme Employees
Marizyme had 13 employees as of December 31, 2022. The number of employees increased by 2 or 18.18% compared to the previous year.
Employees
13
Change (1Y)
2
Growth (1Y)
18.18%
Revenue / Employee
$42,284
Profits / Employee
-$5,309,125
Market Cap
6.59M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 13 | 2 | 18.18% |
| Dec 31, 2021 | 11 | -7 | -38.89% |
| Dec 31, 2020 | 18 | 17 | 1,700.00% |
| Dec 31, 2018 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
MRZM News
- 3 months ago - Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™ - GlobeNewsWire
- 9 months ago - Marizyme CEO Delivers Business Update - GlobeNewsWire
- 10 months ago - Marizyme, Inc. Announces FDA Clearance for Flagship Product, DuraGraft™ - GlobeNewsWire
- 1 year ago - Marizyme Announces IP Developments for DuraGraft® and Its Pipeline Products - GlobeNewsWire
- 2 years ago - Marizyme Announces Allowance of Patent Application for Flagship Product DuraGraft by United States Patent and Trademark Office - GlobeNewsWire
- 2 years ago - Marizyme Announces the Closing of My Health Logic Acquisition Along With Initial Financing - GlobeNewsWire
- 2 years ago - Marizyme Inc. Announces Results of GOAL Study Presented at 7th Annual International Coronary Congress - GlobeNewsWire
- 2 years ago - Marizyme Announces Expansion of Patent Portfolio Into Several Key Territories - GlobeNewsWire